i.norgaard

TL2 · Lyon

Contributes reviews on supplier material. Based in Lyon.

Joined 28 May 2025 · last posted 9h

88 posts, newest first. Showing up to 150.

What to bring: records that a clinician can actually use — a second dataset Replied, post #86 · Clinical › Prescriber conversations · 28 Jul 2026 · 0 likes Taking post #83 at face value and following it one step further. Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes,…
A site rotation scheme that is easy enough to actually follow Replied, post #123 · Practice › Administration · 24 Jul 2026 · 30 likes Site rotation scheme is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says…
Common supplements people ask about, assessed one at a time Replied, post #86 · Practice › Interactions · 23 Jul 2026 · 9 likes Anything that also slows gut motility compounds the same mechanism. That is a plausibility argument rather than a documented interaction, and it should be labelled as…
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #45 · Compounds › Secretagogues & GH axis · 17 Jul 2026 · 0 likes The pulsatile character of endogenous growth hormone release is why a secretagogue and exogenous growth hormone are not interchangeable, and why a single measured level…
Submitting a sample: the process end to end Replied, post #80 · Sourcing › Independent verification · 13 Jul 2026 · 11 likes Adding thanks rather than a view. I do not have a view worth the space.
Revisiting: How this community labels and discusses unrefereed work Replied, post #19 · Evidence › Preprints · 9 Jul 2026 · 0 likes Unrefereed work is not worthless and a great deal of it survives review substantially unchanged. That is the accurate framing and it is not a licence to treat it as…
Why we ask for units every single time, with three examples of what goes wrong Replied, post #97 · Start Here › How to Ask · 4 Jul 2026 · 22 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
Spreadsheets: an appreciation — what changed since Replied, post #90 · Lounge › Off topic · 4 Jul 2026 · 32 likes Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
Heart failure with preserved ejection fraction: symptom endpoints Replied, post #14 · Clinical › Comorbidities · 2 Jul 2026 · 0 likes An update on my earlier heart failure with preserved ejection post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
Tracking intake honestly when appetite is absent Replied, post #80 · Nutrition & Training › Protein & intake · 30 Jun 2026 · 0 likes Micronutrient adequacy becomes a real question at very low total intake and is much less discussed than protein. Take it as a starting point and not as a specification.
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #19 · Practice › Side effects · 28 Jun 2026 · 4 likes Coming back to post #17, because the follow-up matters more than the original answer. Vomiting: when it is expected (first-dose reactions or early titration) and when…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #39 · Sourcing › Independent verification · 24 Jun 2026 · 13 likes Where I part company with post #37, and it is a narrow parting. PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both…
Splitting an overlong document into two Replied, post #27 · Documentation › Wiki requests · 22 Jun 2026 · 6 likes A document with no maintainer becomes wrong quietly, which is worse than not existing, because it carries the authority of a maintained page.
The headache that turns out to be dehydration — the long version Replied, post #53 · Nutrition & Training › Hydration & electrolytes · 19 Jun 2026 · 0 likes Coming back to post #51, because the follow-up matters more than the original answer. I read the earlier replies on headache twice before writing this, because I had…
Molecular mass of semaglutide and why the figure differs between sources Replied, post #75 · Compounds › Semaglutide · 10 Jun 2026 · 10 likes Post #74 is the version of this I will quote in future. One addition. The most useful thing anyone has posted about molecular mass of semaglutide in this category was a…
Mood changes: monitoring, and when to involve a professional — what changed since Replied, post #10 · Wellbeing › Mental health · 9 Jun 2026 · 27 likes This follows post #9 rather than contradicting it. Any change in mood that is persistent, or that includes thoughts of self-harm, is a reason to contact a clinician…
Second pass at: Absence of evidence and evidence of absence Replied, post #16 · Research Methods › Statistics · 6 Jun 2026 · 0 likes Building on post #15 rather than restating it. Absence of evidence came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the…
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #15 · Compounds › Semaglutide · 31 May 2026 · 8 likes Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The acylation is the reason for the long half-life and it is also the reason…
What to include when your question involves a chromatogram — one year on Replied, post #16 · Start Here › How to Ask · 26 May 2026 · 23 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #64 · Practice › Reconstitution · 21 May 2026 · 19 likes A cake that takes a few minutes to dissolve is ordinary. A cake that will not dissolve after gentle swirling and standing at room temperature is worth raising with the…
Batch numbers that do not match the vial label — what changed since Replied, post #14 · Sourcing › Red flags · 15 May 2026 · 3 likes Picking up post #11: that is the part I would want checked first. Careful with the language on Batch numbers. "Not detected" and "not present" are different findings…
What consumer-accessible tests can and cannot determine Replied, post #2 · Analytics › Home & field testing · 12 May 2026 · 20 likes Agreed, and I will stop repeating the version of this I had been repeating.
Secretagogues and glucose tolerance: the mechanistic concern Started this topic · Compounds › Secretagogues & GH axis · 10 May 2026 · 2 likes On the subject in the title: Secretagogues and glucose tolerance: the mechanistic concern Working notes rather than a conclusion. Secretagogues and glucose tolerance,…
Racemisation and why it is invisible to a mass measurement — what changed since Replied, post #5 · Analytics › Impurities & related substances · 7 May 2026 · 0 likes Aggregates may be a multiple of the monomer mass and may not elute at all under a standard method. What does not come off the column does not appear in the area…
Anaesthesia and elective surgery: the aspiration question Replied, post #101 · Practice › Interactions · 26 Apr 2026 · 2 likes Renal or hepatic impairment changes the calculus for a lot of combinations and is the context most often missing from an interaction question here.
Packaging that arrived damaged: documenting it properly Started this topic · Sourcing › Logistics · 19 Apr 2026 · 26 likes Packaging that arrived damaged: documenting it properly Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since…
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #75 · Analytics › Mass spectrometry · 12 Apr 2026 · 1 like Everything in post #73 holds. The case it does not cover is the one I have. Charge states sits at the boundary between what this community can usefully discuss and what…
Revisiting: Drawing up with one needle and injecting with another Replied, post #11 · Practice › Administration · 1 Apr 2026 · 15 likes Building on post #10 rather than restating it. A new needle for each injection is not fussiness. A needle blunts on first use and a blunted needle is the reason the…
The anatomy of a question that gets answered within an hour Replied, post #8 · Start Here › How to Ask · 31 Mar 2026 · 10 likes This is the sort of exchange that makes the archive worth searching.
The "under review" status pill and when a moderator applies it Replied, post #46 · Evidence › Preprints · 30 Mar 2026 · 0 likes A preprint with the data and code attached is frequently more checkable than a published paper without them. Reviewed and reproducible are different properties. I have…
[2026 update] What a purity-only report leaves out Replied, post #35 · Sourcing › Independent verification · 25 Feb 2026 · 0 likes Understood, and I withdraw the assumption I opened with.
Measurement error in a self-reported exposure Replied, post #25 · Evidence › Study critique · 23 Feb 2026 · 14 likes Building on post #22 rather than restating it. Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real.…
Amylin receptor signalling and satiety — what changed since Replied, post #34 · Pharmacology › Receptor biology · 22 Feb 2026 · 14 likes This follows post #32 rather than contradicting it. GLP-1 receptor agonism produces its metabolic effects through more than one route: central satiety signalling,…
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #35 · Evidence › Trials · 21 Feb 2026 · 0 likes That is a cleaner way of putting what I was circling around.
Why one laboratory's 98.4% and another's 96.1% may not contradict — one year on Replied, post #6 · Analytics › Method validation · 17 Feb 2026 · 2 likes The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number. I…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #31 · Practice › Dosing & titration · 16 Feb 2026 · 18 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #53 · Evidence › Study critique · 14 Feb 2026 · 28 likes Confirming post #50 from a second method, which matters more than confirming it from a second person. Criticism is more useful when it is narrower. "The trial answers a…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #105 · Access › International · 12 Feb 2026 · 32 likes Worth separating two things that post #102 runs together. Where a compound is approved under a different trade name in another market, searching the local name finds…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #141 · Documentation › Doc review · 27 Jan 2026 · 9 likes Marking my uncertainty on Promotion criteria explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
A single out-of-range value on an otherwise normal panel Replied, post #7 · Clinical › Bloodwork · 21 Jan 2026 · 6 likes Rate of change is frequently more informative than absolute value, and it is only available if the earlier results were kept.
Request declined, with reasoning — what changed since Replied, post #6 · Meta › Feature requests · 16 Jan 2026 · 18 likes Feature request I expect to be refused, stated anyway: a private notes field on a topic, visible only to me. I keep those in a text file and the text file loses the link.
Vomiting: when it is expected and when it is a reason to stop Replied, post #117 · Practice › Side effects · 30 Dec 2025 · 20 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #49 · Compounds › Tirzepatide · 7 Dec 2025 · 11 likes Narrowing post #46, because the general version has more than one answer. Comparisons between the tirzepatide and semaglutide programmes across trials rather than…
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #67 · Practice › Reconstitution · 25 Nov 2025 · 3 likes Everything in post #63 holds. The case it does not cover is the one I have. Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort…
What pooling buys you and what it destroys Replied, post #72 · Evidence › Meta-analyses · 21 Nov 2025 · 12 likes Good question, well framed, and I would like to see it answered properly.
[2026 update] What steady state means for the decision to escalate Replied, post #93 · Practice › Dosing & titration · 14 Nov 2025 · 33 likes On steady state I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads…
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #30 · Sourcing › Regulatory · 14 Nov 2025 · 10 likes Post #28 describes the usual case. This is about the unusual one. Pharmaceutical compounding rules came up in a thread eighteen months ago and was answered well. I…
The anatomy of a question that gets answered within an hour — the long version Replied, post #57 · Start Here › How to Ask · 4 Nov 2025 · 20 likes Post #54 is right about the mechanism and I think understates the practical bit. It is fine to say you cannot explain why you are asking. Nobody will press, and the…
Payment mechanics and the recovery options that do not exist Started this topic · Sourcing › Payments · 18 Oct 2025 · 1 like Payment mechanics and the recovery options that do not exist Writing it up because I had to work it out twice and would rather nobody else did. A payments question,…
Reading a supplier's product description as a marketing document Replied, post #79 · Compounds › Other compounds · 4 Oct 2025 · 1 like Grateful for the specificity. Vague answers to this question are what sent me looking.
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #46 · Lounge › Off topic · 20 Sep 2025 · 20 likes A digression that keeps occurring to me: the most-linked documents here are the dullest ones. Nothing gets cited like the unit-arithmetic page.
Pinch or no pinch, and how needle length changes the answer Replied, post #53 · Practice › Administration · 9 Sep 2025 · 8 likes Pinch is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes before…
Journal club: STEP-HFpEF and symptom endpoints — a second dataset Replied, post #7 · Evidence › Journal club · 3 Sep 2025 · 0 likes Narrowing post #6, because the general version has more than one answer. Reading back through the step-hfpef and symptom endpoints threads from last year, the same…
A ten-fold dose error caught before injection Replied, post #91 · Devices › Syringes & needles · 30 Aug 2025 · 9 likes The reason ten-fold dose error caught is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the…
Guidelines revision: what changed and why — one year on Replied, post #9 · Meta › Announcements · 20 Aug 2025 · 0 likes Post #6 answers the question as asked. The question underneath it is different. The edit is clearer. For anyone arriving now, read the edited version — the confusion in…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #18 · Evidence › Journal club · 11 Aug 2025 · 22 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
Why catalogue breadth is not evidence of anything — what changed since Replied, post #16 · Compounds › Other compounds · 10 Aug 2025 · 2 likes Post #15 is right about the mechanism and I think understates the practical bit. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical…
Temperature loggers worth the money — the long version Replied, post #6 · Devices › Cold chain · 30 Jun 2025 · 0 likes Temperature excursions: brief excursions above 8 °C are tolerable for most compounds. Hours to a day at room temperature is usually acceptable. Days to weeks at room…
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #31 · Evidence › Journal club · 19 Jun 2025 · 15 likes Post #28 is the version of this I will quote in future. One addition. I would rather this thread reach "we do not know" about STEP 4 than reach a confident answer that…
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #59 · Compounds › Cagrilintide & amylin analogues · 10 Jun 2025 · 0 likes Taking post #58 at face value and following it one step further. Since CagriSema phase 2 paper keeps coming up, it should probably be a maintained page rather than a…
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #18 · Devices › Pens & autoinjectors · 9 Jun 2025 · 8 likes Research-use-only material does not come in a metering device, and adapting one is neither straightforward nor something anyone here can validate for you.
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #52 · Compounds › Cagrilintide & amylin analogues · 7 Jun 2025 · 0 likes Adding thanks rather than a view. I do not have a view worth the space.
Anxiety in the first weeks: drug, situation, or both Replied, post #93 · Wellbeing › Mental health · 25 May 2025 · 2 likes I had written a reply contradicting post #91 and deleted it. Here is what survived. Support and community: some people process weight change through community (online…
Pregnancy as an absolute contraindication Replied, post #67 · Safety › Contraindications · 19 May 2025 · 5 likes Answering the question post #63 raises rather than the one it answers. Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying.…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #72 · Practice › Reconstitution · 17 May 2025 · 18 likes On reconstituting a multi-strength kit the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Revisiting: German, French and Dutch differences, compared Replied, post #22 · Regional › European Union · 16 May 2025 · 27 likes The arithmetic on German is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
Second pass at: A history of disordered eating: proceeding carefully Replied, post #30 · Wellbeing › Mental health · 7 Apr 2025 · 0 likes Posting my history of disordered eating numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who…
Reading a supplier's product description as a marketing document Replied, post #5 · Compounds › Other compounds · 16 Mar 2025 · 1 like Adding the measurement that post #2 says would settle it. Nicotinamide adenine dinucleotide preparations are not peptides at all and the certificate conventions are…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #81 · Compounds › Cagrilintide & amylin analogues · 15 Mar 2025 · 25 likes Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the slowing at a higher magnitude produces disproportionate…
Consistent declarations and why they matter more than clever ones Replied, post #31 · Sourcing › Logistics · 14 Feb 2025 · 1 like This follows post #30 rather than contradicting it. Reading back through the consistent declarations threads from last year, the same three questions come up every time…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #99 · Evidence › Meta-analyses · 12 Feb 2025 · 0 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
Scheduled maintenance and what will be unavailable Replied, post #39 · Meta › Announcements · 10 Feb 2025 · 0 likes Building on post #37 rather than restating it. Second-hand on scheduled maintenance, so weight it accordingly — someone whose method I trust told me this and I have not…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #62 · Compounds › Cagrilintide & amylin analogues · 7 Feb 2025 · 3 likes Native amylin has awkward physical properties — it aggregates readily, which is why a stable analogue is a pharmaceutical achievement rather than a formulation detail.
Second pass at: A single out-of-range value on an otherwise normal panel Replied, post #3 · Clinical › Bloodwork · 26 Jan 2025 · 0 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Specification in the result column: why that is a meaningful error — the long version Replied, post #10 · Analytics › COA interpretation · 23 Jan 2025 · 25 likes A test date preceding a manufacturing date is a clerical error until somebody explains otherwise, and asking is cheap. Most such things are transcription. I have…
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #33 · Devices › Cold chain · 8 Jan 2025 · 0 likes Checked the Domestic fridge temperature mapping claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting…
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #64 · Compounds › Semaglutide · 31 Dec 2024 · 0 likes Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate, fibres or frank cloudiness are a different observation entirely…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #74 · Compounds › Oral incretins · 27 Dec 2024 · 2 likes Post #72 and I disagree about the size of the effect, not about the direction. PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial.…
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #39 · Compounds › Semaglutide · 21 Dec 2024 · 2 likes Source for the Molecular mass of semaglutide figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is…
Reading a supplementary appendix and finding the interesting part Replied, post #48 · Evidence › Trials · 20 Dec 2024 · 2 likes Building on post #45 rather than restating it. Composite endpoints should be read component by component. A composite driven entirely by its softest component is a…
[2026 update] How to read a forest plot, properly, from scratch Replied, post #16 · Evidence › Trials · 4 Dec 2024 · 22 likes Post #14 is right about the mechanism and I think understates the practical bit. Risk of bias: structured appraisal of internal validity. Key things to assess:…
Levothyroxine timing: a real interaction with a simple fix Replied, post #7 · Practice › Interactions · 9 Nov 2024 · 0 likes Coming back to post #6, because the follow-up matters more than the original answer. Insulin interaction: semaglutide and tirzepatide are not contraindicated with…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #24 · Compounds › Tirzepatide · 6 Nov 2024 · 9 likes Building on post #21 rather than restating it. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #72 · Compounds › Other compounds · 25 Oct 2024 · 5 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #93 · Nutrition & Training › Hydration & electrolytes · 14 Sep 2024 · 20 likes Constipation and hydration: dehydration makes constipation worse. Increasing fluid intake is the first intervention for constipation alongside other measures. Not a…
Circumference measurements as a poor man's composition estimate Replied, post #56 · Outcomes › Body composition · 10 Aug 2024 · 7 likes Building on post #53 rather than restating it. Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is maintained,…
Guidelines revision: what changed and why Replied, post #53 · Meta › Announcements · 26 Jul 2024 · 2 likes Building on post #50 rather than restating it. When announcements are made: major policy changes, technical changes affecting site function, planned downtime, and…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #25 · Compounds › Retatrutide · 17 Jul 2024 · 14 likes Helpful, and short, which on this subject is harder than long.